H36.811

Clinical Causes: Sickle cell disease, a genetic blood disorder that causes red blood cells to assume an abnormal, sickle or crescent shape Abnormal blood flow and vessel occlusion in the retinal capillaries, leading to ischemia and damage Repeated episodes of sickling and sickling-related vascular occlusions in the retinal vessels Genetic predisposition influencing the severity and presentation of retinopathy

Key Symptoms: Often asymptomatic in early stages, with no noticeable vision changes Possible visual disturbances such as blurred vision or floaters as the disease progresses In some cases, dark spots or loss of peripheral vision may be observed Retinal hemorrhages or microvascular changes detectable through eye examinations

Diagnosis Path: Diagnosis is primarily established through a comprehensive eye examination, including dilated funduscopy, where an ophthalmologist inspects the retina for characteristic signs of sickle-cell related changes. Additional tests such as fluorescein angiography may be performed to assess blood flow and identify areas of ischemia or microvascular abnormalities. These assessments help differentiate nonproliferative sickle-cell retinopathy from other retinal conditions and determine the severity of the disease.

Treatment Protocols: Management of nonproliferative sickle-cell retinopathy focuses on monitoring and preventing progression. Regular eye examinations are crucial for detecting changes early. While no specific medical treatment targets the retinopathy directly in its nonproliferative stage, controlling sickle cell disease overall with appropriate medical care can reduce complications. For advanced or proliferative stages, treatments such as laser therapy or intraocular injections may be employed to prevent worsening of vision or address complications like hemorrhages. Multidisciplinary collaboration involving hematologists and ophthalmologists plays a vital role in comprehensive patient care.